Current developments in anti-HIV/AIDS gene therapy.

Area of Science:

• * Virology and Gene Therapy
• * Immunology and Infectious Diseases

Background:

• * Highly Active Retroviral Therapy (HAART) has significantly improved HIV-1 treatment since 1996.
• * Despite HAART's efficacy, limitations necessitate alternative and complementary therapeutic strategies.
• * HIV-1 replication control remains a challenge for long-term patient management.

Purpose of the Study:

• * To review recent advancements in gene therapy for Human Immunodeficiency Virus type 1 (HIV-1) infection.
• * To highlight progress in identifying new therapeutic targets for HIV-1.
• * To summarize emerging trends and novel tools in HIV-1 gene therapy development.

Main Methods:

• * Comprehensive literature review of gene therapy strategies for HIV-1.
• * Focus on research published between 2006 and 2008.
• * Analysis of therapeutic target selection and tool development in HIV-1 gene therapy.

Main Results:

• * Significant progress in developing novel gene therapy approaches for HIV-1.
• * Identification of new targets and innovative tools to combat HIV-1 replication.
• * Emerging trends indicate a promising future for gene therapy in HIV/AIDS management.

Conclusions:

• * Gene therapy presents a viable alternative or adjunct to HAART for HIV-1 treatment.
• * Continued research into novel targets and tools is crucial for advancing HIV-1 gene therapy.
• * Gene therapy holds potential for more effective and durable control of HIV-1 infection.